UBS Group’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-118
Closed -$1K 11510
2022
Q1
$1K Buy
118
+5
+4% +$49 ﹤0.01% 10084
2021
Q4
$1K Buy
113
+99
+707% +$968 ﹤0.01% 10153
2021
Q3
$0 Hold
14
﹤0.01% 10463
2021
Q2
$0 Buy
+14
New +$137 ﹤0.01% 10110

Other funds holding SSAA

UBS Group's SSAA Position: Q2 2022 in Review

UBS Group sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q2 2022, closing a stake of 118 shares — an estimated $1K sold.

UBS Group first reported a position in SSAA in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 88 funds tracked by Wall St. Rank hold SSAA as of Q2 2022.

  • UBS Group reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 118 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q2 2022, an estimated $1K.
  • UBS Group first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • UBS Group's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $1K in Q1 2022.
  • 88 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.